ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
04/18/2025
Back to search
Official data from USPTO
SIPORE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
04/24/2025
Trademark type
Word
Nice classes
5, 10
Filing date
06/01/2018
Registration date
03/03/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/03/2020
Last transaction
04/24/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
SE
Examiner
INGRAM,KYLE G
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Sigrid Therapeutics AB
Representatives
Bradley L. Cohn Pattishall, McAuliffe, Newbury, Hilliard
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Dietetic preparations adapted for medical use; dietetic substances in the nature of tabletscapsulesliquid formulationsdrinksshotsshakesgelspowders and suspensions adapted for medical use; pharmaceuticals and natural remedies for the treatment and prevention of obesitybeing overweightprediabetesdiabetesglycemic control and for the improvement of overall metabolic health; preparations for use in naturopathy for the treatment and prevention of obesitybeing overweightprediabetesdiabetesglycemic control and for the improvement of overall metabolic health; nutritional supplements; chemical preparations for medical purposes for the treatment and prevention of obesitybeing overweightprediabetesdiabetesglycemic control and for the improvement of overall metabolic health; pharmaceutical preparations and chemico- pharmaceutical preparations for the treatment and prevention of obesitybeing overweightprediabetesdiabetesglycemic control and for the improvement of overall metabolic health; dietary and nutritional supplements; health food supplements for persons with special dietary requirements; chemical preparations for pharmaceutical purposes for the treatment and prevention of obesitybeing overweightprediabetesdiabetesglycemic control and for the improvement of overall metabolic health; pharmaceutical preparations and substances for glycemic control; pharmaceutical preparations and substances for the prevention and treatment of prediabetesdiabetes and for the improvement of overall metabolic health; dietetic preparations and substances for glycemic control; dietetic preparations and substances for the prevention and treatment of prediabetesdiabetes and for the improvement of overall metabolic health; dietary and nutritional supplements for glycemic control; dietary and nutritional supplements for the prevention and treatment of prediabetesdiabetes and for the improvement of overall metabolic health; pharmaceutical preparations in the form of tabletscapsulesliquid formulationsdrinksshotsshakesgelspowders and suspensions for use in glycemic control; pharmaceutical preparations in the form of tabletscapsulesliquid formulationsdrinksshotsshakesgelspowders and suspensions for use in the prevention and treatment of prediabetesdiabetes and for the improvement of overall metabolic health; pharmaceutical preparations and substancesdietary and nutritional substances in the form of tabletscapsulesliquid formulationsdrinksshotsshakesgelspowders and suspensionsall for use in the treatment and regulation of obesitybody weightbody fatbody compositionbody weight circumferencecholesterol and LDL cholesterol levelsliver diseasesteatohepatitisinfantile colicgut microbiotainsulin levels and resistanceblood lipidsdiarrheaconstipationcolitis; pharmaceutical preparations and substancesdietary and nutritional substances in the form of tabletscapsulesliquid formulationsdrinksshotsshakesgelspowders and suspensionsall for use in the treatment and regulation of intestinal injury or inflammationCrohn's diseasecardiovascular risk factorspost bariatric surgery patientsnot including products primarily for use in the treatment of angina pectoris and high blood pressure
Class 10
Surgical and medical devices for the treatment and prevention of obesitybeing overweightprediabetesdiabetesglycemic control and for the improvement of overall metabolic health; capsulated medical devices for the treatment and prevention of obesitybeing overweightprediabetesdiabetesglycemic control and for the improvement of overall metabolic health; medical devices for the treatment and prevention of obesity and being overweightfor use in weight control; medical devices for the treatment and prevention of prediabetesdiabetes and glycemic controlfor the improvement of overall metabolic health; medical devices for use in the prevention and treatment of prediabetes and diabetes; orally administered medical devices for the treatment and prevention of obesitybeing overweightprediabetesdiabetesglycemic control and for the improvement of overall metabolic health; surgical and medical devicescapsulated devices and orally administered medical devices all for use in the treatment and regulation of obesitybody weightbody fatbody compositionbody weight circumferencecholesterol and LDL cholesterol levelsliver diseasesteatohepatitisinfantile colicgut microbiotainsulin levels and resistanceblood lipidsdiarrheaconstipationintestinal injury or inflammationcolitisCrohn's diseasecardiovascular risk factorspost bariatric surgery patients
Publications
History of USPTO decisions and trademark events.
38 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/03/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/02/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/29/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/24/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/08/2020
FIMP
FINAL DISPOSITION PROCESSED
07/08/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/03/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
03/03/2020
GPNX
NOTIFICATION PROCESSED BY IB
12/20/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/17/2019
PUBO
PUBLISHED FOR OPPOSITION
12/17/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/04/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/04/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/27/2019
ALIE
ASSIGNED TO LIE
11/14/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/10/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/05/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/04/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/04/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/13/2019
GNFR
FINAL REFUSAL E-MAILED
06/13/2019
CNFR
FINAL REFUSAL WRITTEN
06/13/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/04/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/03/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/03/2019
ATRV
ATTORNEY REVIEW COMPLETED
02/08/2019
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
02/07/2019
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
02/01/2019
RFNT
REFUSAL PROCESSED BY IB
12/21/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/04/2018
RFRR
REFUSAL PROCESSED BY MPU
12/04/2018
MAFR
APPLICATION FILING RECEIPT MAILED
11/23/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/21/2018
CNRT
NON-FINAL ACTION WRITTEN
11/20/2018
DOCK
ASSIGNED TO EXAMINER
11/19/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/19/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/15/2018
Continuous trademark protection
Get notified about every new filing that threatens SIPORE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.